IP Library Granted Patent US 6,900,027
Granted Patent B1
US 6,900,027 · App. 09/040,161 · Granted May 31, 2005

Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,900,027
App. No.
09/040,161
Granted
May 31, 2005
Kind
B1
Abstract

An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying the best treatment or agent for the particular patient. The system includes the initial preparation of cohesive multicellular particulates of the tissue sample, rather than enzymatically dissociated cell suspensions or preparations, for initial tissue culture monolayer preparation. Practical monolayers of cells may thus be formed to enable meaningful screening of a plurality of treatments and/or agents. By subjecting uniform samples of cells to a wide variety of active agents (and concentrations thereof), the most promising agent and concentration for treatment of a particular patient can be determined. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated.

Claims (20)

1. A method for preparing a biopsy sample of tissue containing malignant cells for chemosensitivity testing, comprising:

(a) obtaining a tumor specimen from a biopsy sample of tissue containing malignant cells;

(b) mechanically separating said specimen into cohesive multicellular particulates having smooth cut edges;

(c) growing a tissue culture monolayer from said cohesive multicellular particulates having smooth cut edges;

(d) inoculating cells from said monolayer into a plurality of segregated sites;

(e) treating said plurality of sites with at least one agent; and

(f) assessing chemosensitivity of the cells in said plurality of sites.

2. The method according to claim 1 wherein said plurality of segregated sites comprise a plate containing a plurality of wells therein.

3. The method according to claim 2 wherein said plurality of wells is treated over a length of timed adequate to permit assessment of both initial cytotoxic effect and longer term inhibitory effect of at least one of said plurality of active agents.

4. The method according to claim 3 wherein step (d) is accomplished by a multiple well pipetting device.

5. The method according to claim 4 wherein the cells in step (d) are further suspended in medium prior to inoculation into said plate containing a plurality of wells therein.

6. The method according to claim 1 wherein said agent is at least one of the agents selected from the group consisting of a radiation therapy agent, a radiation therapy sensitizing agent and a radiation therapy desensitizing agent.

7. The method according to claim 1 wherein said agent is an immunotherapeutic agent.

8. A method for preparing a biopsy sample of tissue containing malignant cells for chemosensitivity testing, comprising:

(a) obtaining a tumor specimen from a biopsy sample of tissue containing malignant cells;

(b) mechanically separating said specimen into cohesive multicellular particulates of minced tumor tissue;

(c) growing a tissue culture monolayer from said cohesive multicellular particulates of minced tumor tissue;

(d) inoculating cells from said monolayer into a plurality of segregated sites;

(e) treating said plurality of sites with at least one agent; and

(f) assessing chemosensitivity of the cells in said plurality of sites.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2016
From: HELOMICS CORPORATION
To: CYTOMICS, INC.
Reel/Frame 040529/0022 →
CHANGE OF NAME Recorded Dec 15, 2014
From: PRECISION THERAPEUTICS, INC.
To: HELOMICS CORPORATION
Reel/Frame 034638/0930 →
SECURITY AGREEMENT Recorded Mar 23, 2012
From: PRECISION THERAPEUTICS, INC.
To: COWEN HEALTHCARE ROYALTY PARTNERS II, L.P.
Reel/Frame 027922/0459 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2007
From: NATIONAL CITY BANK OF PENNSYLVANIA
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 019725/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2007
From: KORNBLITH, PAUL L.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 019690/0964 →
MERGER Recorded Jan 8, 2002
From: PRECISION THERAPEUTICS, INC.
To: PRECISION THERAPEUTICS, INC.
Reel/Frame 012437/0785 →
SECURITY INTEREST Recorded Jul 29, 1999
From: PRECISION THERAPEUTICS, INC.
To: NATIONAL CITY BANK OF PENNSYLVANIA
Reel/Frame 010121/0542 →